A comprehensive World Health Organization report released Monday reveals that psychiatric medication use among children and adolescents has skyrocketed by 400 per cent globally since 2000, sparking intense debate about whether the mental health crisis is being properly addressed or dangerously over-medicated.
The data, compiled from 47 countries including Canada, shows that antidepressant prescriptions for youth aged 10-17 have increased from 2.1 million in 2000 to 10.5 million in 2025, while antipsychotic medications prescribed to the same age group rose from 780,000 to 3.8 million during the same period.
"We're seeing unprecedented levels of mental health challenges among young people, but we must question whether pharmaceutical intervention has become the default response rather than addressing root causes," said Dr. Sarah Chen, a child psychiatrist at Alberta Children's Hospital who was not involved in the WHO study.
The report indicates that Canada ranks among the highest prescribers of youth psychiatric medications, with Alberta showing a 380 per cent increase in such prescriptions over the past two decades. The province's Assured Income for the Severely Handicapped (AISH) program has seen a corresponding rise in mental health-related claims, with over 40 per cent of new applicants citing psychiatric conditions as their primary disability.
"These statistics represent real young people whose lives have been fundamentally altered by psychiatric interventions that may not be serving their best interests," said Margaret Sullivan, director of advocacy group Families for Safe Mental Health.
Critics argue that the dramatic increase reflects a systemic failure to address underlying factors contributing to youth mental health struggles, including social media pressures, academic stress, family breakdown, and economic uncertainty. Instead, they contend, the medical establishment has increasingly turned to pharmaceutical solutions that may create long-term dependency without resolving core issues.
The WHO report also highlights concerning trends in involuntary psychiatric holds for minors, which have increased by 250 per cent since 2015. In Alberta alone, emergency psychiatric assessments for youth rose from 1,200 annually in 2010 to over 4,800 in 2025, straining hospital resources and traumatizing families.
Faith-based organizations and community groups have reported success with alternative approaches emphasizing family support, spiritual guidance, and community connection. The Calgary-based Faith and Family Mental Health Initiative has documented significant improvements in youth wellbeing through programs that avoid pharmaceutical interventions in favour of counselling, mentorship, and spiritual care.
"Young people need hope, purpose, and genuine human connection—not just chemical band-aids that may mask symptoms while creating new problems," said Rev. David Mitchell, who coordinates mental health outreach programs across Alberta's faith communities.
The pharmaceutical industry maintains that increased prescription rates reflect better diagnosis and treatment of previously unrecognized mental health conditions. However, internal documents obtained through freedom of information requests reveal aggressive marketing campaigns targeting parents, teachers, and healthcare providers to expand medication use among children.
Mental health advocates are calling for comprehensive reform that prioritizes community-based support, family counselling, and addressing social determinants of mental health over institutional psychiatric treatment. The Calgary Forums community discussion platform has seen thousands of parents sharing concerns about their children's experiences with psychiatric medications and seeking alternatives.
As governments worldwide grapple with rising mental health costs and questionable outcomes, the WHO report serves as a stark reminder that current approaches may be causing more harm than healing for vulnerable young people seeking genuine recovery and hope.